Existing drugs could be used to tackle dementia, say scientists
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Medications used to treat hypertension, diabetes and skin conditions could also treat dementia, according to new research.
The study by King's College London identified four existing drugs and one drug class which could reduce the risk or slow down symptoms of the disease.
The Alzheimer's Society, which funded the research, said the use of drugs already available could be a cheaper and quicker way of tackling dementia.
But the charity admitted more work was needed to understand how the drugs could work for sufferers.
The report's lead author, Professor Clive Ballard, who represents King's College London and the Alzheimer's Society, said: "Defeating dementia is one of the biggest challenges facing both medicine and society as a whole.
"Developing new drugs to treat the condition is incredibly important, but comes with a huge price tag and, for those affected by dementia, an unimaginable wait.
"This study identifies existing treatments and shows the potential to identify other similar drugs which are safe and if effective in clinical trials could be used to treat Alzheimer's disease in 10 years or less. We are urgently working to take this work forward to start making a difference to the lives of people with dementia."
The report concluded that there was "strong evidence regarding the potential value" of calcium channel blockers substantially reducing the risk of dementia.
Dr Ann Johnson, 59, from Manchester, who lives with Alzheimer's disease, said: "Access to drug treatments has made a huge difference to my life.
"Before I was prescribed them I knew what I wanted to say but I couldn't find the right words. I had low self-esteem and used to dread getting lost. It was terrifying. Now I'm able to live life to the full.
"I'm lucky that I've found an Alzheimer's drug that works for me. However, these drugs don't work for everyone so we must continue the search for more and better options."
The report will be published in the Nature Reviews Drug Discovery journal.
The drugs or classes of drugs identified as potential treatments are:
:: High blood pressure medications including Nilvadipine, from the calcium channel blockers family.
:: Diabetes medications exenatide and liraglutide, which have been shown to stimulate the brain.
:: Minocycline, an antibiotic used to treat acne.
:: Acitretin, a drug used to treat psoriasis which researchers found modifies the way proteins linked to dementia form.
PA
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments